Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
True and sustainable results still come from the right combination of nutrition, training, recovery, and lifestyle
Arillotta D, Floresta G, Guirguis A, et al
J Biol Chem 276:29596602 Fratelli M, Demol H, Puype M, Casagrande S, Eberini I, Salmona M, Bonetto V, Mengozzi M, Duffieux F, Miclet E, Bachi A, Vanekerckhove J, Gianazza E, Ghezzi P (2002) Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes
The role of AMP-activated protein kinase in the action of ethanol in the liver
Farxiga/Forxiga (dapagliflozin) Disease area(s): Metabolic diseases Manufacturer(s): AstraZeneca 2024 Sales (USD): $7.72 billion Why it sold so well: In 2024, AstraZenecas Farxiga achieved robust sales growth, with revenues increasing by 21% year-over-year to $1.9 billion in the fourth quarter alone and by 28% compared to 2023, making it the companys top seller in 2024
US$ 21.02
US$ 26.68
US$ 24.36
US$ 28.55
US$ 29.44
US$ 29.29
US$ 23.24
US$ 29.56
US$ 23.01
US$ 28.52
US$ 28.59
